Beyond inherited repeat length: somatic expansions in Huntington disease.
Huntington disease timing depends not just on inherited mutations but on ongoing DNA instability in the brain, opening new avenues to slow progression.
This review synthesizes evidence that somatic CAG expansions—beyond the inherited repeat length—are a critical driver of Huntington disease onset timing and regional brain vulnerability, explaining much of the clinical variability. This opens new avenues for therapeutic intervention targeting the somatic instability pathway rather than the inherited mutation alone.
What the study was
- Study design
- Review of somatic CAG repeat expansion evidence in Huntington disease and its implications for disease variability and therapeutic targeting
- Population
- Individuals with Huntington disease
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- Current Opinion in Genetics & Development
Why it surfaced
Emerging evidence that somatic CAG instability explains HD variability positions genome-instability modifiers as novel therapeutic targets for this fatal rare disease; timely given recent HD therapeutic advances.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.